Skip to main content

Table 1 Distribution of community- and hospital-acquired infections, with their length of treatment

From: Identifying excessive length of antibiotic treatment duration for hospital-acquired infections: a semi-automated approach to support antimicrobial stewardship

 

Community-acquired, n (% of total CAI)

LOT in days, [median; IQR]

Hospital-acquired, n (% of total HAI)

LOT in days, [median; IQR]

Total, n (% of total infections)

Intra-abdominal infection *

1191 (15.4)

6.0 [4.0–9.0]

435 (15.3)

6.0 [4.0–10.0]

1626 (15.4)

RTI-CAP-m

672 (8.7)

6.0 [4.0–8.0]

71 (2.5)

6.0 [4.0–7.0]

743 (7.0)

RTI-CAP-s

215 (2.8)

5.0 [3.0–7.0]

23 (0.8)

5.0 [3.5-6.0]

238 (2.3)

RTI-HAP

126 (1.6)

6.0 [4.0–8.0]

234 (8.3)

6.0 [4.0–8.0]

360 (3.4)

RTI-COPD

147 (1.9)

7.0 [3.0–8.0]

33 (1.2)

6.0 [3.0–8.0]

180 (1.7)

RTI-Aspiration

175 (2.3)

7.0 [3.0–9.0]

88 (3.1)

7.0 [5.0–9.0]

263 (2.5)

RTI-abscess/empyema

50 (0.6)

14.5 [6.3–24.8]

14 (0.5)

33.0 [16.8–41.5]

64 (0.6)

RTI-other (not specified)

302 (3.9)

6.0 [3.0–9.0]

72 (2.5)

6.5 [4.8–8.3]

374 (3.5)

UTI-cystitis

845 (10.9)

6.0 [2.0–9.0]

505 (17.8)

6.0 [4.0–8.0]

1350 (12.8)

UTI-complicated

544 (7.0)

11.0 [5.0–15.0]

106 (3.7)

11.0 [6.0–15.0]

650 (6.2)

UTI-kidney transplant

144 (1.9)

14.0 [7.0–15.0]

40 (1.4)

11.0 [4.8–15.3]

184 (1.7)

UTI-Catheter- related

87 (1.1)

9.0 [3.0–15.0]

64 (2.3)

7.0 [4.0–11.0]

151 (1.4)

UTI-other (not specified)

193 (2.5)

8.0 [3.0–14.0]

42 (1.5)

6.5 [2.0-11.8]

235 (2.2)

Bone or joint infection

470 (6.1)

8.0 [2.0–16.0]

97 (3.4)

8.0 [3.0–16.0]

567 (5.4)

CNS infection

112 (1.4)

7.0 [3.0-14.3]

35 (1.2)

8.0 [6.5–12.5]

147 (1.4)

E.N.T. or oral and maxillofacial

212 (2.7)

10.0 [7.0–13.0]

90 (3.2)

9.0 [6.0–11.0]

302 (2.9)

Febrile neutropenia

59 (0.8)

5.0 [3.0-6.5]

123 (4.3)

4.0 [4.0–6.0]

182 (1.7)

Gastro-enteritis

105 (1.4)

5.0 [3.0–9.0]

39 (1.4)

6.0 [3.0-9.5]

144 (1.4)

Gynaecological infection

377 (4.9)

2.0 [1.0–8.0]

78 (2.8)

2.0 [1.0–5.0]

455 (4.3)

CVL infection

108 (1.4)

6.0 [3.0–11.0]

74 (2.6)

5.0 [3.0–8.0]

182 (1.7)

Mediastinitis

48 (0.6)

8.0 [3.0–15.0]

14 (0.5)

8.5 [7.0-14.8]

62 (0.6)

SAB

67 (0.9)

13.0 [8.00-18.5]

22 (0.8)

15.5 [12.0–16.0]

89 (0.8)

Sepsis e.c.i.

717 (9.3)

4.0 [2.0–7.0]

319 (11.3)

5.0 [3.0–7.0]

1036 (9.8)

Skin or soft tissue infection

672 (8.7)

11.00 [6.0–15.0]

195 (6.9)

10.0 [6.0–13.0]

867 (8.2)

Not further specified*

91 (1.2)

 

22 (0.8)

 

113 (1.1)

Total

7729

6.0 [3.0–7.0]

2835

6.0 [4.0–10.0]

10,564

  1. * Numbers are n(%)
  2. ** Indications rarely chosen (less than 50 times in dataset)
  3. CAI = community-acquired infection, HAI = hospital-acquired infection, LOT = length of treatment, RTI = respiratory tract infection, CAP-m = mild-to-moderate severe community-acquired pneumonia (PSI 1–2), CAP-s = severe community- acquired pneumonia (PSI 3–5), HAP = hospital-acquired pneumonia, COPD = chronic obstructive pulmonary disease, UTI = urinary tract infection, CNS = central nervous system, E.N.T. = ear, nose, and throat, CVL = central venous line, SAB = Staphylococcus aureus bacteremia
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us